IMMUNE PHARMACEUTICALS INC's ticker is IMNP and the CUSIP is 45254C101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $65,000 | -19.8% | 447,068 | 0.0% | 0.00% | – |
Q4 2016 | $81,000 | +20.9% | 447,068 | +84.2% | 0.00% | – |
Q3 2016 | $67,000 | +71.8% | 242,723 | +142.9% | 0.00% | – |
Q2 2016 | $39,000 | -7.1% | 99,919 | 0.0% | 0.00% | – |
Q1 2016 | $42,000 | -42.5% | 99,919 | 0.0% | 0.00% | – |
Q4 2015 | $73,000 | -37.6% | 99,919 | 0.0% | 0.00% | – |
Q3 2015 | $117,000 | – | 99,919 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Geduld E E | 35,000 | $66,000 | 0.04% |
Ifrah Financial Services, Inc. | 20,956 | $40,000 | 0.02% |
Bank Pictet & Cie (Europe) AG | 12,900 | $25,000 | 0.01% |
Pine River Capital Management L.P. | 250,000 | $286,000 | 0.00% |
Spark Investment Management LLC | 13,500 | $25,000 | 0.00% |
A.R.T. Advisors, LLC | 10,201 | $19,000 | 0.00% |
CITIGROUP INC | 346 | $1,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 32,745 | $62,000 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 20,000 | $38,000 | 0.00% |
MORGAN STANLEY | 126 | $0 | 0.00% |